Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor.
Pablo Garcia-ManauErika BonacinaBerta SerranoSara CaamiñaMarta RicartEva Lopez-QuesadaÀngels VivesMonica LopezElena PintadoAnna MarotoSara CatalanMarta DalmauEsther Del BarcoAlina HernandezMarta MiserachsMarta San JoseMireia Armengol-AlsinaElena CarrerasManel MendozaPublished in: Acta obstetricia et gynecologica Scandinavica (2023)
Routine first-trimester screening for pre-eclampsia with placental growth factor leads to a reduction in preterm pre-eclampsia and other pregnancy complications. Aspirin treatment compliance has a great impact on the effectiveness of this screening program.
Keyphrases
- growth factor
- randomized controlled trial
- systematic review
- clinical practice
- preterm birth
- low dose
- quality improvement
- low birth weight
- risk factors
- type diabetes
- cardiovascular disease
- cardiovascular events
- acute coronary syndrome
- atrial fibrillation
- gestational age
- preterm infants
- percutaneous coronary intervention
- antiplatelet therapy
- combination therapy